Ironwood Pharmaceuticals
IRWD
IRWD
165 hedge funds and large institutions have $195M invested in Ironwood Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 51 increasing their positions, 48 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.16% more ownership
Funds ownership: 90.35% → 91.51% (+1.2%)
6% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 48
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
165
Holding in Top 10
1
Calls
$14.7M
Puts
$26K
Top Buyers
| 1 | +$8.63M | |
| 2 | +$1.3M | |
| 3 | +$596K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$556K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$529K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.34M | |
| 3 | -$879K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$815K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$563K |
